Literature DB >> 9439608

Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae.

A S Ghosh1, J Ahamed, K K Chauhan, M Kundu.   

Abstract

Shigella dysenteriae represent one of the growing list of antibiotic-resistant bacteria. Quinolones are widely employed to treat shigellosis. However, quinolone resistance has already been reported, necessitating an understanding of the mechanisms of development of resistance. We demonstrate that high-level fluoroquinolone resistance of S. dysenteriae exposed to these antibiotics may occur in the absence of gyrA mutations and involve a proton motive force(pmf)-dependent efflux system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9439608     DOI: 10.1006/bbrc.1997.7902

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Mechanisms of quinolone resistance in clinical isolates of Shigella dysenteriae.

Authors:  J Ahamed; J Gangopadhyay; M Kundu; A K Sinha
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

Review 2.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.

Authors:  D Dagan; N Orr; M Yavzori; Y Yuhas; D Meron; S Ashkenazi; D Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

4.  Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.

Authors:  Shanta Dutta; Yoshiaki Kawamura; Takayuki Ezaki; Gopinath Balakrish Nair; Ken-Ichiro Iida; Shin-Ichi Yoshida
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Multiple resistance mechanisms acting in unison in an Escherichia coli clinical isolate.

Authors:  Dhriti Mallik; Akash Kumar; Sujoy Kumar Sarkar; Anindya S Ghosh
Journal:  Curr Microbiol       Date:  2013-08-02       Impact factor: 2.188

6.  Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli.

Authors:  D G White; L J Piddock; J J Maurer; S Zhao; V Ricci; S G Thayer
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

7.  gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.

Authors:  H Oh; N El Amin; T Davies; P C Appelbaum; C Edlund
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

8.  Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.

Authors:  Kaisar A Talukder; Bijay K Khajanchi; Mohammad A Islam; Zhahirul Islam; Dilip K Dutta; Mustafizur Rahman; Haruo Watanabe; Gopinath B Nair; David A Sack
Journal:  Curr Microbiol       Date:  2006-01-31       Impact factor: 2.188

9.  Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae.

Authors:  Somesh Baranwal; Keya Dey; T Ramamurthy; G Balakrish Nair; Manikuntala Kundu
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 10.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.